Structural investigations on the mitochondrial uncouplers niclosamide and FCCP

Mei Ying Ng,Zhi Jian Song,Choon Hong Tan,Marcella Bassetto,Thilo Hagen
DOI: https://doi.org/10.1002/2211-5463.13817
2024-05-17
FEBS Open Bio
Abstract:Uncoupler compounds such as niclosamide and FCCP increase fuel oxidation and are a potential treatment for obesity and hepatosteatosis. However, FCCP and niclosamide exhibit undesirable effects by inhibiting mitochondrial oxygen consumption and inducing DNA damage. Through structural investigations, we characterized the role of specific functional groups in mediating uncoupling and side effects, providing important information to aid further drug development. There has been renewed interest in using mitochondrial uncoupler compounds such as niclosamide and carbonyl cyanide p‐(trifluoromethoxy)phenylhydrazone (FCCP) for the treatment of obesity, hepatosteatosis and diseases where oxidative stress plays a role. However, both FCCP and niclosamide have undesirable effects that are not due to mitochondrial uncoupling, such as inhibition of mitochondrial oxygen consumption by FCCP and induction of DNA damage by niclosamide. Through structure–activity analysis, we identified FCCP analogues that do not inhibit mitochondrial oxygen consumption but still provided good, although less potent, uncoupling activity. We also characterized the functional role of the niclosamide 4′‐nitro group, the phenolic hydroxy group and the anilide amino group in mediating uncoupling activity. Our structural investigations provide important information that will aid further drug development.
biochemistry & molecular biology
What problem does this paper attempt to address?